Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 3
2006 4
2007 10
2010 4
2011 7
2012 6
2013 9
2014 9
2015 6
2016 10
2017 8
2018 5
2019 5
2020 9
2021 7
2022 10
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
Bhatt DL, Szarek M, Pitt B, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Inzucchi SE, Kosiborod MN, Cherney DZI, Dwyer JP, Scirica BM, Bailey CJ, Díaz R, Ray KK, Udell JA, Lopes RD, Lapuerta P, Steg PG; SCORED Investigators. Bhatt DL, et al. N Engl J Med. 2021 Jan 14;384(2):129-139. doi: 10.1056/NEJMoa2030186. Epub 2020 Nov 16. N Engl J Med. 2021. PMID: 33200891 Clinical Trial.
Neuroprotective Effect of SGLT2 Inhibitors.
Pawlos A, Broncel M, Woźniak E, Gorzelak-Pabiś P. Pawlos A, et al. Among authors: broncel m. Molecules. 2021 Nov 28;26(23):7213. doi: 10.3390/molecules26237213. Molecules. 2021. PMID: 34885795 Free PMC article. Review.
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, Aboyans V, Alings M, Kakkar AK, Keltai K, Maggioni AP, Lewis BS, Störk S, Zhu J, Lopez-Jaramillo P, O'Donnell M, Commerford PJ, Vinereanu D, Pogosova N, Ryden L, Fox KAA, Bhatt DL, Misselwitz F, Varigos JD, Vanassche T, Avezum AA, Chen E, Branch K, Leong DP, Bangdiwala SI, Hart RG, Yusuf S; COMPASS Investigators. Anand SS, et al. Lancet. 2018 Jan 20;391(10117):219-229. doi: 10.1016/S0140-6736(17)32409-1. Epub 2017 Nov 10. Lancet. 2018. PMID: 29132880 Free article. Clinical Trial.
BCG and SARS-CoV-2-What Have We Learned?
Kulesza J, Kulesza E, Koziński P, Karpik W, Broncel M, Fol M. Kulesza J, et al. Among authors: broncel m. Vaccines (Basel). 2022 Sep 30;10(10):1641. doi: 10.3390/vaccines10101641. Vaccines (Basel). 2022. PMID: 36298506 Free PMC article. Review.
COVID-19: Direct and Indirect Mechanisms of Statins.
Pawlos A, Niedzielski M, Gorzelak-Pabiś P, Broncel M, Woźniak E. Pawlos A, et al. Among authors: broncel m. Int J Mol Sci. 2021 Apr 17;22(8):4177. doi: 10.3390/ijms22084177. Int J Mol Sci. 2021. PMID: 33920709 Free PMC article. Review.
New possible pharmacological targets for statins and ezetimibe.
Niedzielski M, Broncel M, Gorzelak-Pabiś P, Woźniak E. Niedzielski M, et al. Among authors: broncel m. Biomed Pharmacother. 2020 Sep;129:110388. doi: 10.1016/j.biopha.2020.110388. Epub 2020 Jun 16. Biomed Pharmacother. 2020. PMID: 32559626 Free article. Review.
The effect of maltose modified fourth generation poly(propylene imine) (PPI G4) dendrimers on the barrier functions and inflammatory activation of human vascular endothelium - Possible consequences for the medical application.
Chałubiński M, Szulc A, Gorzelak-Pabiś P, Wojdan K, Appelhans D, Bryszewska M, Broncel M. Chałubiński M, et al. Among authors: broncel m. Vascul Pharmacol. 2022 Apr;143:106972. doi: 10.1016/j.vph.2022.106972. Epub 2022 Feb 14. Vascul Pharmacol. 2022. PMID: 35176515 Review. No abstract available.
111 results